Cytochrome P450 monooxygenases: an update on perspectives for synthetic application.
暂无分享,去创建一个
[1] D. Nelson. The Cytochrome P450 Homepage , 2009, Human Genomics.
[2] R. Müller,et al. Genome Mining in Sorangium cellulosum So ce56 , 2009, The Journal of Biological Chemistry.
[3] H. Ikeda,et al. Regio- and Stereospecificity of Filipin Hydroxylation Sites Revealed by Crystal Structures of Cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis* , 2010, The Journal of Biological Chemistry.
[4] Heung-Chae Jung,et al. ENGINEERING BACTERIAL CYTOCHROME P450 BM3 INTO A PROTOTYPE WITH HUMAN P450 ENZYME ACTIVITY USING INDIGO FORMATION , 2010 .
[5] R. Bernhardt,et al. Towards Preparative Scale Steroid Hydroxylation with Cytochrome P450 Monooxygenase CYP106A2 , 2010, Chembiochem : a European journal of chemical biology.
[6] S. Kelly,et al. Biosynthesis of the Sesquiterpene Antibiotic Albaflavenone in Streptomyces coelicolor A3(2)* , 2008, Journal of Biological Chemistry.
[7] Vlada B Urlacher,et al. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. , 2011, Chemical communications.
[8] Matthias Dietrich,et al. Cytochrome P450 monooxygenase from Clostridium acetobutylicum: a new alpha-fatty acid hydroxylase. , 2007, Biochemical and biophysical research communications.
[9] E. Gillam. Engineering cytochrome p450 enzymes. , 2008, Chemical research in toxicology.
[10] V. Urlacher,et al. Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system , 2009, Microbial cell factories.
[11] F. Guengerich,et al. Characterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm. , 2010, Molecular interventions.
[12] Kersten S. Rabe,et al. Engineering and assaying of cytochrome P450 biocatalysts , 2008, Analytical and bioanalytical chemistry.
[13] S. Bell,et al. Cytochrome P450 enzymes from the metabolically diverse bacterium Rhodopseudomonas palustris. , 2006, Biochemical and biophysical research communications.
[14] F. Guengerich,et al. Human cytochrome P450 4F11: heterologous expression in bacteria, purification, and characterization of catalytic function. , 2010, Archives of biochemistry and biophysics.
[15] T. Imanaka,et al. Synthesis of optically pure S-sulfoxide by Escherichia coli transformant cells coexpressing the P450 monooxygenase and glucose dehydrogenase genes , 2011, Journal of Industrial Microbiology & Biotechnology.
[16] D. Nelson,et al. Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish , 2010, BMC Genomics.
[17] F. Arnold,et al. Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s. , 2007, Chemistry & biology.
[18] N. Vermeulen,et al. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. , 2007, Journal of medicinal chemistry.
[19] J. Ishikawa,et al. Hydroxylation of Testosterone by Bacterial Cytochromes P450 Using the Escherichia coli Expression System , 2006, Bioscience, biotechnology, and biochemistry.
[20] N. Vermeulen,et al. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. , 2008, Chemico-biological interactions.
[21] R. Lill,et al. Parallel pathways for oxidation of 14‐membered polyketide macrolactones in Saccharopolyspora erythraea , 2002, Molecular microbiology.
[22] Sabine Laschat,et al. Rational Design of a Minimal and Highly Enriched CYP102A1 Mutant Library with Improved Regio‐, Stereo‐ and Chemoselectivity , 2009, Chembiochem : a European journal of chemical biology.
[23] W. Soetaert,et al. The role of cytochrome P450 monooxygenases in microbial fatty acid metabolism , 2011, The FEBS journal.
[24] L. Narhi,et al. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. , 1986, The Journal of biological chemistry.
[25] H. Ikeda,et al. Crystal Structures of Cytochrome P450 105P1 from Streptomyces avermitilis: Conformational Flexibility and Histidine Ligation State , 2008, Journal of bacteriology.
[26] Colin J Jackson,et al. The Cytochrome P450 Complement (CYPome) of Streptomyces coelicolor A3(2)* , 2002, The Journal of Biological Chemistry.
[27] T. Friedberg,et al. Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli. , 2006, Methods in molecular biology.
[28] R. Bernhardt,et al. Cytochrome P450 systems--biological variations of electron transport chains. , 2007, Biochimica et biophysica acta.
[29] Santosh Kumar. Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation , 2010, Expert opinion on drug metabolism & toxicology.
[30] D. Nelson,et al. Progress in tracing the evolutionary paths of cytochrome P450. , 2011, Biochimica et biophysica acta.
[31] Vlada B Urlacher,et al. Cytochrome P450 monooxygenases: perspectives for synthetic application. , 2006, Trends in biotechnology.
[32] T. Eguchi,et al. Cloning and Characterization of the Biosynthetic Gene Cluster of 16‐Membered Macrolide Antibiotic FD‐891: Involvement of a Dual Functional Cytochrome P450 Monooxygenase Catalyzing Epoxidation and Hydroxylation , 2010, Chembiochem : a European journal of chemical biology.
[33] V. Urlacher. Catalysis with Cytochrome P450 Monooxygenases , 2010 .
[34] J. Schrader,et al. Improvement of P450BM-3 whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli , 2008, Applied Microbiology and Biotechnology.
[35] H. Sugimoto,et al. Crystal structure of CYP105A1 (P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3. , 2008, Biochemistry.
[36] K. Auclair,et al. Progress towards the easier use of P450 enzymes. , 2006, Molecular bioSystems.
[37] F Peter Guengerich,et al. Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery , 2006, Expert opinion on drug metabolism & toxicology.
[38] F Peter Guengerich,et al. Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.
[39] Michael Schroeder,et al. SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions , 2009, Nucleic Acids Res..
[40] F. Arnold,et al. How proteins adapt: lessons from directed evolution. , 2009, Cold Spring Harbor symposia on quantitative biology.
[41] F. Arnold,et al. Improved product‐per‐glucose yields in P450‐dependent propane biotransformations using engineered Escherichia coli , 2011, Biotechnology and bioengineering.
[42] S. Lütz,et al. Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe. , 2010, Journal of biotechnology.
[43] T. Ahn,et al. Functional expression of human cytochrome P450 enzymes in Escherichia coli. , 2006, Current drug metabolism.
[44] F. Arnold,et al. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.
[45] F. Arnold,et al. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. , 2006, Biotechnology and bioengineering.
[46] R. Bernhardt,et al. Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. , 2006, Journal of biotechnology.
[47] R. Bernhardt,et al. Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.
[48] M. Klingenberg. Pigments of rat liver microsomes. , 2003, Archives of biochemistry and biophysics.
[49] Andreas Schmid,et al. Practical issues in the application of oxygenases. , 2003, Trends in biotechnology.
[50] Y. Uno,et al. Bioconversion of small molecules by cytochrome P450 species expressed in Escherichia coli , 2008, Biotechnology and applied biochemistry.
[51] L. Maltais,et al. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. , 2004, Pharmacogenetics.
[52] V. Urlacher,et al. Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis , 2010, Applied Microbiology and Biotechnology.
[53] E. Gillam,et al. Membrane integration of recombinant human P450 forms , 2009, Xenobiotica; the fate of foreign compounds in biological systems.
[54] Jeffrey B. Endelman,et al. Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450 , 2006, PLoS biology.
[55] N. Kagawa,et al. The CYPome of Sorangium cellulosum So ce56 and identification of CYP109D1 as a new fatty acid hydroxylase. , 2010, Chemistry & biology.
[56] P. Ortiz de Montellano,et al. Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system , 2009, Biotechnology Letters.
[57] H. Ikeda,et al. Cytochrome p450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2). , 2003, Biochemical and biophysical research communications.
[58] Søren Bak,et al. Comparative Genomics of Rice and Arabidopsis. Analysis of 727 Cytochrome P450 Genes and Pseudogenes from a Monocot and a Dicot1[w] , 2004, Plant Physiology.
[59] J. F. Aparicio,et al. Structure of cytochrome P450 PimD suggests epoxidation of the polyene macrolide pimaricin occurs via a hydroperoxoferric intermediate. , 2010, Chemistry & biology.
[60] J. Sohng,et al. Cytochrome P450 (CYP105F2) from Streptomyces peucetius and its activity with oleandomycin , 2008, Applied Microbiology and Biotechnology.
[61] D. Kelly,et al. The Mechanism of the Acyl-Carbon Bond Cleavage Reaction Catalyzed by Recombinant Sterol 14α-Demethylase of Candida albicans (Other Names Are: Lanosterol 14α-Demethylase, P-45014DM, and CYP51) (*) , 1996, The Journal of Biological Chemistry.
[62] E. Gillam. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s. , 2007, Archives of biochemistry and biophysics.
[63] C. Rienstra,et al. High-yield expression and purification of isotopically labeled cytochrome P450 monooxygenases for solid-state NMR spectroscopy. , 2007, Biochimica et biophysica acta.
[64] Frances H Arnold,et al. Cytochrome P450: taming a wild type enzyme. , 2011, Current opinion in biotechnology.
[65] K. Purnapatre,et al. Cytochrome P450s in the development of target-based anticancer drugs. , 2008, Cancer letters.
[66] Kazuhiro MACHIDA,et al. Organization of the Biosynthetic Gene Cluster for the Polyketide Antitumor Macrolide, Pladienolide, in Streptomyces platensis Mer-11107 , 2008, Bioscience, biotechnology, and biochemistry.
[67] M. Sutcliffe,et al. Thermodynamic and biophysical characterization of cytochrome P450 BioI from Bacillus subtilis. , 2004, Biochemistry.
[68] Alexander Seifert,et al. Identification of selectivity‐determining residues in cytochrome P450 monooxygenases: A systematic analysis of the substrate recognition site 5 , 2009, Proteins.
[69] H. Agematu,et al. A Modular Approach to Biotransformation Using Microbial Cytochrome P450 Monooxygenases , 2007 .
[70] R. Bernhardt,et al. Coexpression of redox partners increases the hydrocortisone (cortisol) production efficiency in CYP11B1 expressing fission yeast Schizosaccharomyces pombe. , 2008, Journal of biotechnology.
[71] C. Wolf,et al. Recombinant Yeast and Bacteria that Express Human P450s: Bioreactors for Drug Discovery, Development, and Biotechnology , 2007 .
[72] H. Sahm,et al. Functional expression of the glucose transporter of Zymomonas mobilis leads to restoration of glucose and fructose uptake in Escherichia coli mutants and provides evidence for its facilitator action , 1995, Journal of bacteriology.
[73] T. Tsuchida,et al. One-pot fermentation of pladienolide D by Streptomyces platensis expressing a heterologous cytochrome P450 gene. , 2009, Journal of bioscience and bioengineering.
[74] P. Ortiz de Montellano,et al. Rearrangement reactions catalyzed by cytochrome P450s. , 2011, Archives of biochemistry and biophysics.
[75] Jürgen Pleiss,et al. The Cytochrome P450 Engineering Database: integration of biochemical properties , 2009, BMC Biochemistry.
[76] David Baker,et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). , 2009, ACS chemical biology.
[77] Bongsoo Park,et al. Fungal cytochrome P450 database , 2008, BMC Genomics.
[78] Toshiki Furuya,et al. Genome mining approach for the discovery of novel cytochrome P450 biocatalysts , 2010, Applied Microbiology and Biotechnology.
[79] Frances H Arnold,et al. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. , 2007, Angewandte Chemie.
[80] D. Kelly,et al. The CYPome (Cytochrome P450 complement) of Aspergillus nidulans. , 2009, Fungal genetics and biology : FG & B.
[81] Eun Jung Kim,et al. Regioselective hydroxylation of daidzein using P450 (CYP105D7) from Streptomyces avermitilis MA4680 , 2010, Biotechnology and Bioengineering.
[82] G. Grogan. Cytochromes P450: exploiting diversity and enabling application as biocatalysts. , 2011, Current opinion in chemical biology.
[83] A. Munro,et al. Cytochrome P450--redox partner fusion enzymes. , 2007, Biochimica et biophysica acta.
[84] N. Turner,et al. Cytochromes P450 as useful biocatalysts: addressing the limitations. , 2011, Chemical communications.
[85] John A. Robinson,et al. An oxidative phenol coupling reaction catalyzed by oxyB, a cytochrome P450 from the vancomycin-producing microorganism. , 2004, Angewandte Chemie.
[86] F. Arnold,et al. A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. , 2009, Chemistry.
[87] D. Kelly,et al. The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans (other names are: lanosterol 14 alpha-demethylase, P-45014DM, and CYP51). , 1996, The Journal of biological chemistry.
[88] J. Schrader,et al. P450BM-3-catalyzed whole-cell biotransformation of α-pinene with recombinant Escherichia coli in an aqueous–organic two-phase system , 2009, Applied Microbiology and Biotechnology.
[89] H. Sugimoto,et al. Crystal structures and catalytic mechanism of cytochrome P450 StaP that produces the indolocarbazole skeleton , 2007, Proceedings of the National Academy of Sciences.
[90] A W Munro,et al. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme. , 2005, Biochemical Society transactions.